Blood Res.  2023 Dec;58(4):221-224. 10.5045/br.2023.2023049.

Incidental abdominal computed tomography findings in patients newly diagnosed with Philadelphia-negative myeloproliferative neoplasm

• Song IC
• Koh JS
• Kang S
• Lee MW
• Shin KS
• Jo DY

• KMID: 2550200
• DOI: http://doi.org/10.5045/br.2023.2023049

Reference

1. Song IC, Yeon SH, Lee MW, et al. 2021; Thrombotic and hemorrhagic events in 2016 World Health Organization-defined Philadelphia- negative myeloproliferative neoplasm. Korean J Intern Med. 36:1190–203. DOI: 10.3904/kjim.2020.634. PMID: 34289585. PMCID: PMC8435504. PMID: 1171ae3cdf6c42e4a204252610a84058.

2. Hong J, Lee JH, Byun JM, et al. 2019; Risk of disease transformation and second primary solid tumors in patients with myeloproliferative neoplasms. Blood Adv. 3:3700–8. DOI: 10.1182/bloodadvances.2019000655. PMID: 31765478. PMCID: PMC6880910.

3. Song IC, Yeon SH, Lee MW, et al. 2022; Myelofibrotic and leukemic transformation in 2016 WHO-defined Philadelphia-negative myeloproliferative neoplasm. Blood Res. 57:59–68. DOI: 10.5045/br.2021.2021209. PMID: 35256550. PMCID: PMC8958372.

4. Tefferi A, Barbui T. 2020; Polycythemia vera and essential thrombocythemia: 2021 update on diagnosis, risk-stratification and management. Am J Hematol. 95:1599–613. DOI: 10.1002/ajh.26008. PMID: 32974939.

5. Passamonti F. 2012; How I treat polycythemia vera. Blood. 120:275–84. DOI: 10.1182/blood-2012-02-366054. PMID: 22611155.

6. Sant'Antonio E, Guglielmelli P, Pieri L, et al. 2020; Splanchnic vein thromboses associated with myeloproliferative neoplasms: an international, retrospective study on 518 cases. Am J Hematol. 95:156–66. DOI: 10.1002/ajh.25677. PMID: 31721282.

7. Lee MW, Yeon SH, Ryu H, et al. 2021; Volumetric splenomegaly in patients with essential thrombocythemia and prefibrotic/early primary myelofibrosis. Int J Hematol. 114:35–43. DOI: 10.1007/s12185-021-03121-x. PMID: 33704663.

8. Lee MW, Yeon SH, Ryu H, et al. 2022; Volumetric splenomegaly in patients with polycythemia vera. J Korean Med Sci. 37:e87. DOI: 10.3346/jkms.2022.37.e87. PMID: 35315598. PMCID: PMC8938613.

9. Lee MW, Yeon SH, Ryu H, et al. 2022; Splenic infarction in patients with Philadelphia-negative myeloproliferative neoplasms. Intern Med. 61:3483–90. DOI: 10.2169/internalmedicine.9124-21. PMID: 35527026. PMCID: PMC9790792.

10. Barbui T, Ghirardi A, Masciulli A, et al. 2019; Second cancer in Philadelphia negative myeloproliferative neoplasms (MPN-K). A nested case-control study. Leukemia. 33:1996–2005. DOI: 10.1038/s41375-019-0487-8. PMID: 31142846.

11. Arber DA, Orazi A, Hasserjian R, et al. 2016; The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 127:2391–405. DOI: 10.1182/blood-2016-03-643544. PMID: 27069254.

12. Chang CC, Kuo JY, Chan WL, Chen KK, Chang LS. 2007; Prevalence and clinical characteristics of simple renal cyst. J Chin Med Assoc. 70:486–91. DOI: 10.1016/S1726-4901(08)70046-7. PMID: 18063502.

13. Shimizu T, Yoshioka M, Kaneya Y, et al. 2022; Management of simple hepatic cyst. J Nippon Med Sch. 89:2–8. DOI: 10.1272/jnms.JNMS.2022_89-115. PMID: 34526451.

14. Kwon OS, Kim YK, Her KH, Kim HJ, Lee SD. 2020; Physical activity can reduce the prevalence of gallstone disease among males: an observational study. Medicine (Baltimore). 99:e20763. DOI: 10.1097/MD.0000000000020763. PMID: 32590752. PMCID: PMC7329018.

15. Paley MR, Ros PR. 1998; Hepatic calcification. Radiol Clin North Am. 36:391–8. DOI: 10.1016/S0033-8389(05)70030-0. PMID: 9520990.